跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Zoladex Goserelin 3.6mg (as acetate) Implant syringe - TGA Drug Approval Details
Approvals
/
TGA
/
Zoladex Goserelin 3.6mg (as acetate) Implant syringe
Approved
STANDARD
Zoladex Goserelin 3.6mg (as acetate) Implant syringe
AstraZeneca Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
379634c6574cd747
Company
AstraZeneca Pty Ltd
Type
Standard
Approval Details
Approval Id
379634c6574cd747
Product Name
Zoladex Goserelin 3.6mg (as acetate) Implant syringe
Artg Id
24368
Artg Name
ZOLADEX Goserelin 3.6mg (as Acetate) Implant Syringe
Sponsor
AstraZeneca Pty Ltd
Company Detail Path
/organization/astrazeneca-pty-ltd
Artg Date
1991-10-14
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-CMI-04915-3
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-04914-3
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
379634c6574cd747
Type
Standard
Back to TGA Approvals